WCM Investment Management LLC Buys 19 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

WCM Investment Management LLC boosted its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 0.8% in the first quarter, HoldingsChannel reports. The firm owned 2,441 shares of the biotechnology company’s stock after acquiring an additional 19 shares during the period. WCM Investment Management LLC’s holdings in Axon Enterprise were worth $1,306,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Axon Enterprise in the 1st quarter worth approximately $1,110,000. CX Institutional bought a new stake in Axon Enterprise in the 1st quarter worth approximately $115,000. GAMMA Investing LLC grew its position in Axon Enterprise by 11.8% in the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after purchasing an additional 154 shares during the period. Blue Trust Inc. grew its position in Axon Enterprise by 33.1% in the 1st quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company’s stock worth $89,000 after purchasing an additional 42 shares during the period. Finally, Xponance Inc. grew its position in Axon Enterprise by 3.5% in the 4th quarter. Xponance Inc. now owns 16,469 shares of the biotechnology company’s stock worth $9,788,000 after purchasing an additional 560 shares during the period. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of a number of research analyst reports. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research report on Thursday, May 8th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Barclays boosted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research report on Friday, May 9th. Bank of America boosted their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a “buy” rating in a research report on Wednesday, June 4th. Finally, The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $699.55.

Insider Activity at Axon Enterprise

In related news, CRO Cameron Brooks sold 3,000 shares of Axon Enterprise stock in a transaction on Friday, May 30th. The shares were sold at an average price of $740.76, for a total transaction of $2,222,280.00. Following the transaction, the executive owned 19,447 shares in the company, valued at approximately $14,405,559.72. The trade was a 13.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 9,905 shares of the business’s stock in a transaction on Wednesday, May 21st. The stock was sold at an average price of $738.03, for a total transaction of $7,310,187.15. Following the completion of the sale, the president owned 298,809 shares in the company, valued at approximately $220,530,006.27. The trade was a 3.21% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock worth $30,500,428 in the last 90 days. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Up 2.7%

AXON opened at $795.48 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.62 and a current ratio of 2.83. Axon Enterprise, Inc has a fifty-two week low of $279.02 and a fifty-two week high of $830.21. The firm’s fifty day moving average is $733.14 and its 200 day moving average is $634.69. The stock has a market cap of $61.93 billion, a price-to-earnings ratio of 192.14, a price-to-earnings-growth ratio of 89.16 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The company had revenue of $603.63 million for the quarter, compared to analysts’ expectations of $585.67 million. During the same quarter in the previous year, the company earned $1.15 EPS. Axon Enterprise’s revenue for the quarter was up 31.3% on a year-over-year basis. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.